Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Jun 30.
Published in final edited form as: Am J Health Educ. 2013 Nov 6;44(6):293–298. doi: 10.1080/19325037.2013.838881

Factors Associated With Adherence to Follow-up Colposcopy

Laura J Fish 1, Patricia G Moorman 2, Lashawn Wordlaw-Stintson 3, Adriana Vidal 4, Jennifer S Smith 5, Cathrine Hoyo 6
PMCID: PMC4075768  NIHMSID: NIHMS571930  PMID: 24991653

Abstract

Background

Understanding the gaps in knowledge about human papilloma virus (HPV) infection, transmission, and health consequences and factors associated with the knowledge gap is an essential first step for the development of interventions to improve adherence to follow-up among women with abnormal Pap smears.

Purpose

To examine the relationship between knowledge about HPV and adherence to scheduled colposcopic evaluation and variables related to lack of knowledge among women with abnormal Pap tests.

Methods

Telephone surveys were conducted with women who attended their scheduled appointments (adherers) and women who did not attend their appointments (nonadherers).

Results

The multivariable analyses indicate that lower HPV knowledge was independently associated with nonadherence to follow-up, controlling for race and education level. Factors related to lower knowledge scores included non-white race, lower education, and lack of health insurance at the time of the scheduled appointment.

Conclusion

Lack of knowledge of HPV was related to nonadherence among women scheduled for colposcopic evaluation.

Translation to Health Education Practice

Health education interventions that deliver complex information about HPV and cervical cancer should be in a format that is accessible and understandable to the women who are most at risk of being nonadherent.

BACKGROUND

Despite population screening rates greater than 80%, the incidence of cervical cancer among US women remains unacceptably high for a largely preventable cancer.1 In 2012, an estimated 12 170 cases of invasive cervical cancer were diagnosed, and an estimated 4220 women died.2 Cervical cancer occurs due to persistent cervical infection with high-risk human papilloma virus (HPV) genotypes.3 The establishment of the causal link between HPV and cervical cancer and a better understanding of cervical carcinogenesis has helped to guide age-appropriate recommendation for screening and follow-up care to prevent cervical cancer.4 With early detection and appropriate follow-up care, the likelihood of survival from cervical cancer is nearly 100%.5 Timely diagnostic follow-up of abnormal results and the availability and utilization of treatment services are needed to effectively reduce invasive cervical cancers.6

Poor adherence to follow-up after abnormal Pap tests has been reported to be associated with younger age,710 African American race/ethnicity,7,11,12 lack of health insurance,10,13,14 less knowledge about HPV, and psychological distress.79,1517 To develop effective interventions to improve adherence to follow-up, more research is needed to identify individual factors potentially amenable to intervention. Generally, knowledge of HPV transmission and prevention among women in the United States is poor.18 Few studies have examined specific gaps in HPV knowledge or predictors of lack of knowledge of HPV among women in general or among women with abnormal Pap tests.19,20 Understanding the gaps in knowledge about HPV infection, transmission, and health consequences and factors associated with the knowledge gap is an essential first step for the development of interventions to improve adherence to follow-up among women with abnormal Pap smears.19 Information alone is insufficient to effect meaningful behavior change; however, basic knowledge of HPV transmission and prevention is a critical building block in any health education efforts to improve adherence among women requiring follow-up to an abnormal Pap test.

PURPOSE

In this article, we examine the relationship between knowledge about HPV transmission and adherence to scheduled follow-up among women with abnormal Pap tests and compare specific gaps in knowledge between women who were adherent and nonadherent to recommended follow-up. In addition, we examined the relationship between demographic variables and lack of knowledge among women with an abnormal Pap smear.

METHODS

The women included in this analysis were a subset of the women who were asked to participate in the Cervical Intraepithelial Neoplasia Cohort Study at Duke University in Durham, North Carolina. The Cervical Intraepithelial Neoplasia Cohort Study is a prospective cohort study that is examining predictors of progression or regression of cervical intraepithelial neoplasia. The study includes women who had cervical cytopathology (Pap) testing at 1 of 10 clinics that are part of the Duke University Health System, had a diagnosis of dysplasia or low-grade squamous intraepithelial lesion, and were scheduled for a follow-up visit at 1 of 4 colposcopy clinics. In accordance with Duke University Health System policy, women with a Pap test requiring follow-up were sent a letter by certified mail informing them of the result and called by the clinic staff to schedule an appointment at a colposcopy clinic. For the present study, women were identified through the electronic clinic appointment logs. In addition to the diagnostic eligibility criteria, women had to be 18 years of age or older, speak English or Spanish, and be mentally competent to give informed consent. Women who attended their scheduled appointment were identified as adherers and women who did not attend their appointments were identified as nonadherers. Interviewers contacted all adherers and nonadherers by telephone after the scheduled appointment to obtain verbal consent and complete the 15-minute telephone survey. The consent script and survey were translated into Spanish and a staff member fluent in Spanish conducted the telephone interviews with Spanish-speaking participants. Initially, all women were offered a $10 retail gift card as an incentive to complete the survey. To effectively recruit nonadherers, the incentive was increased to $25. All study procedures were approved by both the Duke University Medical Center and North Carolina Central University institutional review boards. Recruitment took place between January 2011 and January 2012.

Data Collection

The adherence survey included questions on depression, access and barriers to care, knowledge of HPV and cancer, worry about cervical cancer, and perceived health status. Depression symptoms were measured using the 10-item Center for Epidemiological Studies Depression (CES-D) scale.21 A score of 10 or higher is considered to be associated with significant depressive symptoms. Knowledge of HPV transmission, symptoms, complications, and treatment was assessed using a 16-item instrument developed for this study based on the Health Information National Trends Survey22 and a previously published HPV knowledge scale.23 Examples of items include “HPV can cause cervical cancer,” “HPV can cause genital warts,” “You can get HPV through sexual contact,” and “HPV is rare.” Participants were asked whether they thought each statement was true or false and responses were coded as correct or incorrect. Overall knowledge scores were computed as the percentage of correct answers, with “don’t know” responses coded as incorrect. Perceived health status was measured with 1 item, “How would you describe your current health?” with responses excellent, very good, good, fair, and poor.

Survey data were double entered and analyzed using SAS, Version 9.2 (SAS Institute Inc. Cary, NC, 2010) (PC). We performed statistical analyses comparing women who were adherers and nonadherers and those with high and low knowledge scores using chi-square and Fisher’s exact tests for categorical variables and Student’s t test for continuous variables. Logistic regression modeling was performed first to identify predictors of adherence and then to identify predictors of higher knowledge scores. Variables that were statistically significantly associated with the outcome variables in bivariate analyses were included in the multivariable models.

RESULTS

A total of 586 women (285 adherers and 301 nonadherers) were approached and 92 adherers (32%) and 92 nonadherers (31%) completed the survey. The mean age of the total sample was 29.8 years (range 21–64). The majority of the sample was non-white (57%) and most (80%) of the non-white participants were African American. Fifty-nine percent of the women had completed high school and 78% were not married or living as married. Seventy-one percent of the sample reported having health insurance (private or Medicaid). One quarter (25%) screened positive for depression on the CES-D scale and 49% reported being in excellent or very good health.

There were significant differences between women who returned for a follow-up (adherers) and those who had not (nonadherers; Table 1). In bivariate analysis, the nonadherers were more likely to be non-white (P = .007), have less than high school education (P < .0001), report lower perceived health status (P = .002), and have a CES-D depression score higher than 10 (P = .04). Nonadherers were more likely to have Medicaid or no health insurance compared to adherers (P < .0001). The average knowledge score (percentage correct) was significantly lower among nonadherers compared to those who were adherent (56% and 75%, respectively; P < .0001). In the multivariable adjusted analysis, factors that were significantly associated with nonadherence were being non-white (odds ratio [OR] = 3.7, 95% confidence interval [CI], 1.3–10.1), having less education (OR = 6.6, 95% CI, 23–19.4), and scoring below the mean on the knowledge questions (OR = 1.16, 95% CI, 1.004–1.33). Perceived health status was not a significant predictor of adherence (OR = 0.6, 95% CI, 0.23–1.6; data not shown).

TABLE 1.

Characteristics of Women Who Were Adherent or Nonadherent to Recommended Follow-up of Abnormal Pap Testa

Total (n = 184)
Mean (SD)
Nonadherers (n = 92)
Mean (SD)
Adherers (n = 92)
Mean (SD)
P value
Age (range 21–58 years) 29.8 (8.4) 28.8 (8.4) 30.9 (9.5) .08
Knowledge score (rage 0–100) 66.8 (23.4) 57.9 (24.9) 75.8 (18.1) <.0001
N (%) N (%) N (%)
Race
  White 80 (43) 31 (34) 49 (53) .007
  Non-white 104 (57) 61 (66) 43 (47)
Education
  Less than high school 74 (40) 56 (61) 18 (20) <.0001
  High school or more 109 (60) 36 (39) 73 (80)
Marital status
  Married/living as married 41 (22) 21 (23) 20 (22) .85
  Not married or living as married 143 (78) 71 (77) 72 (78)
Health insurance
  Private 54 (29) 9 (10) 52 (57) <.0001
  Medicaid 69 (38) 51 (55) 18 (20)
  None 61 (33) 32 (35) 22 (24)
Perceived health
  Excellent/very good 89 (48) 34 (37) 55 (60) .002
  Good/fair/poor 95 (52) 58 (63) 37 (40)
CES-D (depression) score
  ≤ 10 138 (75) 63 (68) 75 (82) .04
  > 10 46 (25) 29 (32) 17 (18)
Worry (1–4) 3.0 3.2 .5
Distress: Tension and discomfort (1–4) 1.8 1.7 .5
Distress: Embarrassment (1–4) 1.5 1.4 .25
Distress: Sexual and reproductive consequences (1–4) 1.6 1.6 .8
Distress: Health concerns (1–4) 2.0 1.9 .6
Pain (1–10) 4.1 4.3 .5
a

CES-D indicates Center for Epidemiological Studies Depression Scale. One participant did not provide data on education

Overall, women in this sample answered 67% of the HPV knowledge questions correctly (Table 2). When examining responses to individual questions, we observed that the nonadherent women had a lower proportion of correct answers for each of the 16 items on the scale, with statistically significant differences for 11 of the 16 items. The knowledge gaps were apparent for questions on diseases related to HPV as well as questions about modes of transmission. Though the lack of knowledge was more prominent for women who did not adhere to the recommended follow-up appointment, it is noteworthy that the adherent women also had a high proportion of incorrect answers, especially for the questions about diseases related to HPV infection.

TABLE 2.

Response of HPV Knowledge Questions Among Women Who Were Adherent or Nonadherent to Recommended Follow-up of Abnormal Pap Testa

HPV Knowledge Questions (Correct Answer) % Incorrect % Correct % Don’ Know P Values
HPV can cause cervical cancer (true)
  Adherers 2 89 9 .33
  Nonadherers 1 84 15
HPV infection is rare (false)
  Adherers 15 79 6 <.0001
  Nonadherers 22 53 25
HPV can cause genital warts (true)
  Adherers 18 64 18 .001
  Nonadherers 17 40 43
HPV can cause herpes (false)
  Adherers 29 47 24 .005
  Nonadherers 25 29 46
You can get HPV through sexual contact (true)
  Adherers 2 94 4 <.0001
  Nonadherers 12 65 23
HPV can be cured (false)
  Adherers 26 59 15 .0001
  Nonadherers 37 29 34
HPV can cause penile cancer in men (true)
  Adherers 16 38 46 .17
  Nonadherers 22 25 53
Condoms completely protect against HPV (false)
  Adherers 26 64 10 .17
  Nonadherers 24 59 17
A person may be infected with HPV and not know it (true)
  Adherers 1 97 2 .04
  Nonadherers 0 89 11
Regular pap tests can help to prevent complications (true)
  Adherers 1 96 3 .08
  Nonadherers 0 89 11
Men can carry HPV (true)
  Adherers 2 86 12 <.0001
  Nonadherers 8 52 40
HPV Transmission Questions

A person gets HPV from sharing a plate, fork, or glass with someone who has HPV (false)
  Adherers 8 88 4 .06
  Nonadherers 9 77 14
A person gets HPV from unprotected sexual intercourse with someone who has HPV (true)
  Adherers 1 97 2 <.0003
  Nonadherers 8 77 15
A person gets HPV from oral sex with someone who has HPV (true)
  Adherers 10 72 18 .05
  Nonadherers 17 54 29
A person gets HPV from kissing, with exchange of saliva, with someone who has HPV (false)
  Adherers 19 62 20 .26
  Nonadherers 23 50 27
A person gets HPV from sharing a toilet or shower with someone who has HPV (false)
  Adherers 11 82 8 .19
  Nonadherers 13 71 16
a

HPV indicates human papilloma virus.

We examined predictors of HPV knowledge by comparing women who scored below and above the median percentage of correct answers. In bivariate analysis, non-white race (P = .003), lower education (P < .0001), worse perceived health status (P = .003), and lack of health insurance (P = .006) were related to knowledge (Table 3). Variables that were significantly associated with knowledge in the bivariate analyses were entered into a logistic regression model. In the multivariable adjusted analysis, factors statistically significantly associated with having low HPV knowledge scores were being non-white (OR = 2.9, 95% CI, 1.4–6.0) and having less education (OR = 4.6, 95% CI, 2.1–9.8; data not shown).

TABLE 3.

Bivariate Associations With HPV Knowledge Score

Not Low
Knowledge
(n = 97)
Low
Knowledge
(n = 87)
P value

Mean (SD) Mean (SD)
Age (mean) 30.2 (9.0) 29.4 (7.7) .51
N (%) N (%)
Race
  White 54 (56) 26 (30) .0004
  Non-white 43 (44) 61 (70)
Education
  Less than high school 19 (20) 55 (63) <.0001
  High school or more 80 (80) 32 (37)
Marital status
  Married/living as married 22 (23) 19 (22) .89
  Not married or living as married 75 (77) 68 (78)
Health insurance
  Private 49 (50) 12 (14) <.0001
  Medicaid 24 (25) 45 (52)
  None 24 (25) 30 (34)
Perceived health
  Excellent/very good 56 (58) 33 (38) .007
  Good/fair/poor 41 (42) 54 (62)
Brief CES-D (depression)
  ≤10 75 (77) 63 (72) .44
  >10 22 (23) 24 (28)

HPV indicates human papilloma virus; CES-D, Center for Epidemiological Studies Depression scale. One participant did not provide data on education.

DISCUSSION

Our analyses show that knowledge scores on a series of questions about HPV and its transmission were lower among women with an abnormal Pap test who were nonadherent to the recommended follow-up colposcopy visit compared to women who were adherent. The multivariable analyses indicate that lower HPV knowledge was independently associated with nonadherence to follow-up, controlling for race and education level. In analyses that examined characteristics associated with lower knowledge scores, statistically significant predictors were non-white race and lower education.

Our findings are consistent with previous studies that demonstrate that lower knowledge scores predict nonadherence to recommended follow-up after abnormal Pap testing.20,24 The continued high rate of nonadherence to follow-up after Pap tests and the substantial knowledge deficits suggest the need for improved health education among women who are screened for cervical cancer. Previous studies have shown that patients who do not understand their initial Pap results are more likely not to comply with diagnostic testing.25 Though health education alone is not sufficient for improving follow-up to abnormal Pap smear, decreasing the knowledge gap regarding HPV and cervical cancer is a necessary first step toward improving adherence.

Health education interventions to improve adherence with follow-up to abnormal Pap smears, including telephone counseling, reminder calls, written educational materials, and physician letters, have had modest effects on adherence.26 Data from our study suggest that written materials may not be the optimal way to reach the women most likely to be nonadherent to recommended Pap screening follow-up. In our sample, nearly two thirds of the women who were nonadherent to the recommended follow-up had less than a high school education, compared to only 16% of the women who were adherent. It has been shown that average reading levels are actually lower than the last completed grade.27 Thus, health education materials written at an eighth-grade level may still be too complex for the women most of risk of nonadherence to follow-up recommendations. Further, women with limited reading skills may be disinclined to pick up and read health information brochures.

Regardless of the format of health communication, communicating information about possible outcomes for Pap tests and recommendations for follow-up is particularly complicated. At the time of screening, women need to be made aware that possible outcomes of a Pap screening test are (1) a normal test with no evidence of disease, (2) a diagnosis that requires prompt treatment but may or may not be cancer, or (3) a diagnosis that requires follow-up as in another test to determine the next step. Effective health communication interventions for women with abnormal Pap smears should convey information simply and clearly. Messages should be persuasive enough to convince women of the importance of follow-up evaluation while at the same time minimizing anxiety and distress.28

When interpreting the results, it is important to consider several limitations. First, we were able to complete the survey related to adherence factors on a much smaller proportion of the nonadherers (56%) than the adherers (95%). Although we have no information from the nonrespondents, if the nonrespondents among the nonadherent women were even more likely to have lower education and no health insurance, our results might have been even more striking. Additionally, our analysis does not include other psychosocial factors that are likely related to nonadherence such as fear or worry, and previous research suggests that anxiety and distress also play a significant role in nonadherence.29

TRANSLATION TO PUBLIC HEALTH PRACTICE

Our data show that women who are most at risk have the greatest lack of knowledge about HPV, and the relationship to cervical cancer and lack of knowledge is associated with poor adherence to recommended follow-up. Adherence to follow-up recommendations is essential to the overall prevention of invasive cervical cancer. Though knowledge alone is insufficient for behavior change, it is necessary for women at risk to have a basic understanding of the problem before they can take any preventive action. Health education interventions that deliver complex information about HPV and cervical cancer should be in a format that is accessible and understandable to the women who are most at risk of being nonadherent.

Contributor Information

Laura J. Fish, Duke University Medical Center

Patricia G. Moorman, Duke University Medical Center

Lashawn Wordlaw-Stintson, North Carolina Central University.

Adriana Vidal, Duke University Medical Center.

Jennifer S. Smith, University of North Carolina-Chapel Hill

Cathrine Hoyo, Duke University Medical Center.

REFERENCES

  • 1.Doescher MP, Jackson JE. Trends in cervical and breast cancer screening practices among women in rural and urban areas of the United States. J Public Health Manag Pract. 2009;15:200–209. doi: 10.1097/PHH.0b013e3181a117da. [DOI] [PubMed] [Google Scholar]
  • 2.Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2012;62(1):10–29. doi: 10.3322/caac.20138. [DOI] [PubMed] [Google Scholar]
  • 3.Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518–527. doi: 10.1056/NEJMoa021641. [DOI] [PubMed] [Google Scholar]
  • 4.Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012;62(3):147–172. doi: 10.3322/caac.21139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Eggleston KS, Coker AL, Das IP, Cordray ST, Luchok KJ. Understanding barriers for adherence to follow-up care for abnormal pap tests. J Womens Health (Larchmt) 2007;16:311–330. doi: 10.1089/jwh.2006.0161. [DOI] [PubMed] [Google Scholar]
  • 6.Pierce Campbell CM, Menezes LJ, Paskett ED, Giuliano AR. Prevention of invasive cervical cancer in the United States: past, present, and future. Cancer Epidemiol Biomarkers Prev. 2012;21:1402–1408. doi: 10.1158/1055-9965.EPI-11-1158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Engelstad LP, Stewart S, Otero-Sabogal R, Leung MS, Davis PI, Pasick RJ. The effectiveness of a community outreach intervention to improve follow-up among underserved women at highest risk for cervical cancer. Prev Med. 2005;41:741–748. doi: 10.1016/j.ypmed.2005.06.003. [DOI] [PubMed] [Google Scholar]
  • 8.Ell K, Vourlekis B, Muderspach L, et al. Abnormal cervical screen follow-up among low-income Latinos: Project SAFE. J Womens Health Gend Based Med. 2002;11:639–651. doi: 10.1089/152460902760360586. [DOI] [PubMed] [Google Scholar]
  • 9.Miller SM, Siejak KK, Schroeder CM, Lerman C, Hernandez E, Helm CW. Enhancing adherence following abnormal Pap smears among low-income minority women: a preventive telephone counseling strategy. J Natl Cancer Inst. 1997;89:703–708. doi: 10.1093/jnci/89.10.703. [DOI] [PubMed] [Google Scholar]
  • 10.Peterson NB, Han J, Freund KM. Inadequate follow-up for abnormal Pap smears in an urban population. J Natl Med Assoc. 2003;95:825–832. [PMC free article] [PubMed] [Google Scholar]
  • 11.Benard VB, Lawson HW, Eheman CR, Anderson C, Helsel W. Adherence to guidelines for follow-up of low-grade cytologic abnormalities among medically underserved women. Obstet Gynecol. 2005;105:1323–1328. doi: 10.1097/01.AOG.0000159549.56601.75. [DOI] [PubMed] [Google Scholar]
  • 12.Cardin VA, Grimes RM, Jiang ZD, Pomeroy N, Harrell L, Cano P. Low-income minority women at risk for cervical cancer: a process to improve adherence to follow-up recommendations. Public Health Rep. 2001;116:608–616. doi: 10.1093/phr/116.6.608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Hartz LE, Fenaughty AM. Management choice and adherence to follow-up after colposcopy in women with cervical intraepithelial neoplasia 1. Obstet Gynecol. 2001;98:674–679. doi: 10.1016/s0029-7844(01)01526-5. [DOI] [PubMed] [Google Scholar]
  • 14.Melnikow J, Chan BK, Stewart GK. Do follow-up recommendations for abnormal Papanicolaou smears influence patient adherence? Arch Fam Med. 1999;8:510–514. doi: 10.1001/archfami.8.6.510. [DOI] [PubMed] [Google Scholar]
  • 15.Shinn E, Basen-Engquist K, Le T, et al. Distress after an abnormal Pap smear result: scale development and psychometric validation. Prev Med. 2004;39:404–412. doi: 10.1016/j.ypmed.2004.02.004. [DOI] [PubMed] [Google Scholar]
  • 16.Nelson K, Geiger AM, Mangione CM. Effect of health beliefs on delays in care for abnormal cervical cytology in a multi-ethnic population. J Gen Intern Med. 2002;17:709–716. doi: 10.1046/j.1525-1497.2002.11231.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Jones BA, Novis DA. Follow-up of abnormal gynecologic cytology: a College of American Pathologists Q-Probes study of 16132 cases from 306 laboratories. Arch Pathol Lab Med. 2000;124:665–671. doi: 10.5858/2000-124-0665-FUOAGC. [DOI] [PubMed] [Google Scholar]
  • 18.Klug SJ, Hukelmann M, Blettner M. Knowledge about infection with human papillomavirus: a systematic review. Prev Med. 2008;46(2):87–98. doi: 10.1016/j.ypmed.2007.09.003. [DOI] [PubMed] [Google Scholar]
  • 19.Tiro JA, Meissner HI, Kobrin S, Chollette V. What do women in the US know about human papillomavirus and cervical cancer? Cancer Epidemiol Biomarkers Prev. 2007;16:288–294. doi: 10.1158/1055-9965.EPI-06-0756. [DOI] [PubMed] [Google Scholar]
  • 20.Pruitt SL, Parker PA, Peterson SK, Le T, Follen M, Basen-Engquist K. Knowledge of cervical dysplasia and human papillomavirus among women seen in a colposcopy clinic. Gynecol Oncol. 2005;99(3 suppl 1):S236–S244. doi: 10.1016/j.ygyno.2005.07.095. [DOI] [PubMed] [Google Scholar]
  • 21.Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale) Am J Prev Med. 1994;10(2):77–84. [PubMed] [Google Scholar]
  • 22.Cantor DCK, Crystal-Mansour S, Davis T, Dipko S, Sigman R. Health Information National Trends Survey (HINTS) 2007 Final Report. Rockville, MD: Westat; 2009. [Google Scholar]
  • 23.Yacobi E, Tennant C, Ferrante J, Pal K, Roetzheim R. University students’ knowledge and awareness of HPV. Prev Med. 1999;28:535–541. doi: 10.1006/pmed.1999.0486. [DOI] [PubMed] [Google Scholar]
  • 24.Daley EM, Perrin KM, Vamos C, et al. HPV knowledge among HPV plus women. Am J Health Behav. 2008;32:477–487. doi: 10.5555/ajhb.2008.32.5.477. [DOI] [PubMed] [Google Scholar]
  • 25.Pruitt SL, Parker PA, Follen M, Basen-Engquist K. Communicating colposcopy results: what do patients and providers discuss? J Low Genit Tract Dis. 2008;12(2):95–102. doi: 10.1097/LGT.0b013e31815a5142. [DOI] [PubMed] [Google Scholar]
  • 26.Yabroff KR, Kerner JF, Mandelblatt JS. Effectiveness of interventions to improve follow-up after abnormal cervical cancer screening. Prev Med. 2000;31:429–439. doi: 10.1006/pmed.2000.0722. [DOI] [PubMed] [Google Scholar]
  • 27.Davis TC, Mayeaux EJ, Fredrickson D, Bocchini JA, Jr, Jackson RH, Murphy PW. Reading ability of parents compared with reading level of pediatric patient education materials. Pediatrics. 1994;93:460–468. [PubMed] [Google Scholar]
  • 28.Simon MA, Cofta-Woerpel L, Randhawa V, John P, Makoul G, Spring B. Using the word ‘cancer’ in communication about an abnormal Pap test: finding common ground with patient–provider communication. Patient Educ Couns. 2010;81:106–112. doi: 10.1016/j.pec.2009.11.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kola S, Walsh JC. Determinants of pre-procedural state anxiety and negative affect in first-time colposcopy patients: implications for intervention. Eur J Cancer Care. 2012;21:469–476. doi: 10.1111/j.1365-2354.2011.01317.x. [DOI] [PubMed] [Google Scholar]

RESOURCES